Ambry Genetics
Focus: Ambry Genetics is a public biotechnology company specializing in genetic testing and diagnostics for rare diseases and cancer risk assessment. They operate as a diagnostic and testing services provider with a focus on precision medicine applications.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Ambry Genetics
AI assessmentNot HiringNo open roles listed right now. Follow Ambry Genetics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RT-PCR
RNA Virus InfectionsClinical Trials (1)
NCT04517682COVID-19 and SARS-CoV-2 Detection in Saliva
N/AHelp build intelligence for Ambry Genetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.